Headache Relief Tablet, Coated
NDC Package 70692-142-31

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Headache Relief (acetaminophen, aspirin, caffeine) tablets is • do not use more than directed (see overdose warning)• drink a full glass of water with each dose• adults and children 12 years and over: take 2 caplets every 6 hours; not more than 8 caplets in 24 hours• children under 12 years: ask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-142 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
70692-142-31
Package Description
300 TABLET, COATED in 1 BOTTLE
Product Code
70692-142
11-Digit Billing Format
70692014231
RxNorm Crosswalk
  • RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
  • RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet

Clinical Specifications

Proprietary Name
Headache Relief
Non-Proprietary Name
Acetaminophen, Aspirin, Caffeine
Substance Name
Acetaminophen; Aspirin; Caffeine
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
• do not use more than directed (see overdose warning)• drink a full glass of water with each dose• adults and children 12 years and over: take 2 caplets every 6 hours; not more than 8 caplets in 24 hours• children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc.
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-06-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-142-31 identifies a specific commercial package of 300 tablet, coated in 1 bottle of Headache Relief, a human over the counter drug labeled by Strive Pharmaceuticals Inc.. This tablet, coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc. on April 06, 2023. The current certification is valid through December 31, 2026.

How is this Strive Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692014231. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-142-31
11-Digit CMS (5-4-2)
70692-0142-31

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.